CarlJosephMinnitiSr.MD

Hematology • Mickleton, NJ

Hematologic Oncology

Ceo, the minniti center for medical oncology and hematology

Join to view full profile

Dr. Minniti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Minniti's full profile

Already have an account?

Office
174 Democrat Rd
Mickleton, NJ 08056
Phone+1 856-423-0754

Fax+1 856-423-7508
Is this information wrong?

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1974 - 1976
Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1961 - 1962
Cooper Hospital-University Medical CenterInternship, Transitional Year, 1960 - 1961
Rutgers New Jersey Medical SchoolClass of 1960

Certifications & Licensure

NJ State Medical License 1961 - 2025
PA State Medical License 1974 - 2006
American Board of Internal Medicine Internal Medicine

Clinical Trials

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Active, not recruiting
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
Join now to see all